Spineology leads the way in ultra-minimally invasive spine surgery, revolutionizing how surgeons treat patients with spinal pathologies. Its proprietary technology, OptiMesh sets the company apart from traditional fusion procedures enabling surgeons to optimize outcomes, while minimizing tissue disruption and enhancing patient recovery. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/06/24 | $25,000,000 | Series AA |
1315 Capital RC Capital SV Health Investors  | undisclosed |
